Переход к основному содержанию
 Европа и Центральная Азия Европа и Центральная Азия
  • English
  • русский

Global Links

  • Назад к ЮНИСЕФ
  • Высокий контраст
 Европа и Центральная Азия Европа и Центральная Азия
    • Узнать о ЮНИСЕФ
      • О нас
      • Наш мандат
      • Региональный директор
      • Положение детей в регионе
      • Где мы работаем
      • Портал для родителей
      • Наши голоса: Молодёжь региона
      • Послы ЮНИСЕФ в Европе и Центральной Азии
      • Наши партнеры
  • Пресс-центр
Поддержать

Main navigation

  • Что мы делаем
  • Исследования и отчеты
  • Истории из региона
  • Действуйте
Search area has closed.
Search area has opened.
ПОИСКЗакрыть

Поиск ЮНИСЕФ

  • Доступно на:
  • English
  • русский
  • Українська
  • (-) Заявление (3)
  • Новостные заметки (2)
  • Отчет (3)
  • (-) Пресс-релиз (4)
  • Статья (2)
  • #ОСТАНОВИТЬнасилие (1)
  • (-) COVAX (6)
  • COVID-19 (27)
  • Executive Director (1)
  • Goodwill ambassadors (2)
  • Бедность (1)
  • Бедствия, вызванные деятельностью человека (1)
  • Беженцы (1)
  • (-) ВИЧ/СПИД (0)
  • Вакцины (23)
  • Вооружённый конфликт (4)
  • (-) Гендерное насилие (1)
  • Глобальная инициатива по ликвидации полиомиелита (1)
  • Грудное вскармливание (1)
  • Гуманитарный кризис и реагирование (4)
  • Дети-беженцы и дети-мигранты (2)
  • Защита детей (1)
  • Здравоохранение (13)
  • Изменение климата (1)
  • Изменение климата и его последствия (1)
  • Иммунизация (30)
  • Мигрант и кризис с беженцами (2)
  • Миграция (1)
  • Миграция и кризис с беженцами (1)
  • Образование (2)
  • Охрана здоровья новорожденных (4)
  • Охрана материнского здоровья (2)
  • Питание (4)
  • Питание детей грудного и раннего возраста (1)
  • Полиомиелит (4)
  • Поставка медицинских средств (2)
  • Поставки (2)
  • Права детей (2)
  • Равноправие (1)
  • Учителя (2)
  • Региональный офис ЮНИСЕФ по странам Европы и Центральной Азии (1)
  • Республика Молдова (1)
  • глобальной (5)
Press release
23 Февраль 2021
UNICEF begins shipping syringes for the global rollout of COVID-19 vaccines under COVAX
https://www.unicef.org/eca/press-releases/unicef-begins-shipping-syringes-global-rollout-covid-19-vaccines-under-covax
NEW YORK, 23 February 2021 – UNICEF has sent 100,000 syringes and 1,000 safety boxes for COVID-19 vaccinations to the Maldives by air freight from UNICEF’s humanitarian warehouse in Dubai—part of the first wave of COVID-19-related syringe shipments to begin rolling out in the coming days. Others in the first wave of shipments include Côte d'Ivoire and São Tomé and Príncipe. The 0.5 ml syringes and safety boxes are expected to arrive in Malé, Maldives on Tuesday. Over the next few weeks, UNICEF will ship more than 14.5 million 0.5 ml and 0.3 ml auto-disable syringes to more than 30 countries. While the 0.5 ml syringes are meant for use with the Serum Institute of India/AstraZeneca vaccine, the 0.3 ml ones are to be used with the Pfizer-BioNTech vaccine. “In this global fight against the COVID-19 pandemic, syringes are as vital as the vaccine itself,” said UNICEF Executive Director Henrietta Fore. “It is critical to have adequate supplies of syringes already in place in every country before the vaccine arrives so that the vaccine can be administered safely. This would allow immunization to start immediately and help turn the tide on this terrible virus.” The countries that will receive syringes in this initial tranche are from those included in the  COVAX indicative distribution  and that have put in requests to UNICEF to supply syringes. These shipments will support the country rollout of COVID-19 vaccines, and is part of work by the  COVAX Facility  to provide vaccines to all participating countries. The 0.5 ml syringes are being dispatched from UNICEF’s humanitarian warehouse in Dubai, while the 0.3 ml & 2 ml syringes will be transported directly from a manufacturer in Spain. The consignments will also include safety boxes for the safe disposal of syringes. Both syringes are of the auto-disable type, which means they cannot be used again after a single dose of vaccine has been administered. This reduces the risk of infection from blood-borne diseases as a result of syringe re-use. In all, UNICEF will be supplying up to 1 billion syringes and 10 million safety boxes to countries in 2021 to ensure they are ready for COVID-19 vaccinations. In order to meet the demand for these vital supplies,  UNICEF created a stockpile  of almost half a billion syringes in its warehouses in Copenhagen and Dubai in preparation for the broader rollout of COVID-19 vaccines in 82 low- and lower middle-income countries. UNICEF has been working with airlines, logistics operators and freight forwarders to ensure the syringes are treated as priority freight, whether they are being shipped direct from a manufacturer or from UNICEF warehouses to the destination country’s port of entry. Although the first deliveries will be transported by air, most of the syringes and safety boxes will be transported by sea due to the large amount of space they take up as cargo. UNICEF is aiming to make 2 billion COVID-19 doses available for delivery in 2021. Even before COVID-19, UNICEF was already the largest single vaccine buyer in the world, procuring over 2 billion vaccines annually in order to reach almost half of the world’s children under 5. In addition, the agency procures and supplies around 600-800 million syringes for regular immunization programmes annually. COVAX is a global collaboration co-led by Gavi, the Vaccine Alliance, the Coalition for Epidemic Preparedness Innovations (CEPI) and WHO, and includes UNICEF, which leads on procurement and delivery, as well as getting countries ready to receive vaccines. ##### Двое мужчин на складе с коробками UNICEF/UN0419486/Pableo
Press release
18 Декабрь 2020
UNICEF outlining plans to transport up to 850 tonnes of COVID-19 vaccines per month on behalf of COVAX, in ‘mammoth and historic’ logistics
https://www.unicef.org/eca/press-releases/unicef-outlining-plans-transport-850-tonnes-covid-19-vaccines-month-behalf-covax
NEW YORK, 18 December 2020 – UNICEF could potentially transport up to 850 tonnes of COVID-19 vaccines per month in 2021, should such quantities become available, according to a new assessment. This is more than double the average weight of vaccines UNICEF transports every month. The assessment is part of  UNICEF’s work  to lead on the procurement and delivery of COVID-19 vaccines for 92 low- and lower middle-income countries on behalf of the  COVAX Facility , in collaboration with the Pan American Health Organization (PAHO). “This is a mammoth and historic undertaking,” said Henrietta Fore, UNICEF Executive Director. “The scale of the task is daunting, and the stakes have never been higher, but we are ready to take this on.” The UNICEF assessment looked at global airfreight capacity and transport routes to better understand the challenges of delivering COVID-19 vaccines in 2021. It found that commercial airlines will be able to deliver vaccines to almost all 92 low- and lower-middle-income countries, which are among the 190 economies participating in the COVAX Facility, at an estimated cost of up to US$70 million. Comparing vaccine volume estimates against commercial and cargo routes across the globe, the assessment also found that current air cargo capacity would be sufficient to make deliveries covering 20 per cent of the population for most of the 92 countries. COVID-19 vaccines are expected to be primarily shipped using existing passenger and cargo flight capacity, although charters or alternative transport options may still be needed for some small countries and others with access issues. UNICEF is working with airlines and the wider logistics industry to prioritise the delivery of COVID-19 vaccines around the world. One major challenge in the COVID-19 vaccine operation is local cold chain capacity for vaccine storage within some low- and lower-middle-income countries. UNICEF, WHO and Gavi, the Vaccine Alliance, developed a  guidance note on supply and logistics  to help countries develop their supply chain strategies to receive, store, distribute and manage COVID-19 vaccines and related products. Given the range of storage temperatures required for COVID-19 vaccines, countries will continue to train logisticians and health workers on how to keep COVID-19 vaccines at the right temperatures. As part of  a programme that started in 2017 , with support from Gavi, UNICEF continues to procure and support the installation of 70,000 cold-chain fridges in lower-income countries by the end of 2021, which will help in the roll-out of COVID-19 vaccines that need to be stored at 2 to 8 degrees Celsius. Almost half of these will be solar powered. UNICEF, WHO and Gavi are also working to help countries prepare and develop  national deployment and vaccination plans  for the large-scale roll out of COVID-19 vaccines. Currently, countries are continuing to  monitor their readiness  against key milestones, which include expediting regulatory approvals and putting in place ways to monitor vaccine safety. In addition, a UNICEF meeting this week with more than 300 vaccine procurement experts globally, including government officials, looked at ways to procure and roll-out COVID-19 vaccines and strengthen regulatory systems and supply chains. Funding is critical. UNICEF has called for US$410 million to help countries with the delivery of vaccines, therapeutics and diagnostic tools in 2021. Further, UNICEF estimates a funding gap of US$133 million to cover in-country vaccine logistics and the required cold chain equipment for the poorest 92 countries. “With the imminent arrival of globally approved COVID-19 vaccines, we can begin to see signs of hope. But hope will not be restored by the vaccine alone,” said Fore. “Countries need urgent technical and financial support to strengthen their capacities for cold and supply chains, to train health workers, and to work with communities in combatting misinformation and building trust in vaccines. Without urgent funding and support, many of the poorest countries still risk being left behind.” ###### About COVAX COVAX is the vaccines pillar of the  ACT-Accelerator . It is co-led by the Coalition for Epidemic Preparedness Innovation (CEPI), Gavi, the Vaccine Alliance, and the World Health Organization (WHO) – working in partnership with developed and developing country vaccine manufacturers, UNICEF, the World Bank, Civil Society Organisations and others. COVAX is the only global initiative that is working with governments and manufacturers to ensure COVID-19 vaccines are rapidly available worldwide to economies of all financial means.  Find out more about UNICEF’s work on the COVID-19 vaccines  here , or about UNICEF’s work on immunization  here . Download photos and broll here:  UNICEF shipment UNICEF/UNI319459/Rocio Ortega
Statement
10 Февраль 2021
In the COVID-19 vaccine race, we either win together or lose together
https://www.unicef.org/eca/press-releases/covid-19-vaccine-race-we-either-win-together-or-lose-together
NEW YORK/GENEVA, 10 February 2021 – “Of the 128 million vaccine doses administered so far, more than three quarters of those vaccinations are in just 10 countries that account for 60 per cent of global GDP. “As of today, almost 130 countries, with 2.5 billion people, are yet to administer a single dose. “This self-defeating strategy will cost…
Statement
15 Декабрь 2020
Teachers should be prioritized for vaccination against COVID-19
https://www.unicef.org/eca/press-releases/teachers-should-be-prioritized-vaccination-against-covid-19
NEW YORK, 15 December 2020 – “The COVID-19 pandemic has wreaked havoc on children’s education around the globe. Vaccinating teachers is a critical step towards putting it back on track.  “At their peak in late April 2020, nationwide school closures disrupted the learning of almost 90 per cent of students worldwide. While that number has dropped…
Press release
05 Март 2021
COVID-19 vaccines shipped by COVAX arrive to the Republic of Moldova
https://www.unicef.org/eca/press-releases/covid-19-vaccines-shipped-covax-arrive-republic-moldova
Chisinau, 4 March 2021 - Today Moldova received 14 400 doses of the anti-COVID-19 vaccine, shipped via the COVAX Facility, a partnership between CEPI, Gavi, UNICEF and WHO. Moldova is the first country in Europe to receive vaccines from the COVAX facility.  The arrival marked a historic step towards the goal to ensure equitable distribution of anti-COVID-19 vaccines globally, in what will be the largest vaccine procurement and supply operation in history. The delivery is part of a first wave of arrivals in Moldova that will continue in the coming days and weeks. "We are the first country in Europe to receive a free vaccine through the COVAX platform and we are grateful for that. The 14,400 doses of Covid-19 vaccine will help us continue to immunize medical staff and reduce the spread of the virus. We thank all the states and organizations that support financially this global platform - Germany and other EU Member States, the United States, the United Kingdom of Great Britain and Northern Ireland, Canada, the European Commission, Japan and others - for their solidarity in these difficult times for all. We also thank WHO and UNICEF for their efforts to distribute the vaccines fairly,” said Maia Sandu, the President of the Republic of Moldova. The COVAX Facility is expected to deliver 24,570 doses of BioNTech- Pfizer COVID-19 vaccine and up to 264,000 indicative doses of AstraZeneca / SKBio COVID-19 vaccine to the Republic of Moldova in 2021. Team Europe, bringing together EU and its Member States, is one of the lead contributors to COVAX with over €2.2 billion, including another €900 million recently pledged by Germany. “The European Union continues to support the Republic of Moldova in the fight against COVID-19 pandemic. An equitable and fair access to vaccines is a key element in ending the pandemic.  The European Union and its Member States, acting together as 'Team Europe' are proud to support COVAX in delivering vaccines to our partners and today we see the first vaccines via COVAX platform arriving in the country. This is an important support for continuing the vaccination and the EU has been and will continue to be a reliable partner in this process,” said Peter Michalko, Ambassador of the European Union to the Republic of Moldova. On February 18, 2021 the United States pledged the initial $2 billion - out of a total $4 billion planned - to Gavi, the Vaccine Alliance, to support the global vaccination effort for COVID-19. "Through USAID, the United States contribution of more than $2 billion dollars to the COVAX Vaccine Alliance supports the purchase and delivery of safe and effective vaccines for Moldova’s most vulnerable and at-risk populations, including frontline health care workers. These vaccines are critical to controlling the COVID-19 pandemic and delivering hope that better, happier days are within sight,” said Dereck J. Hogan, U.S. Ambassador to the Republic of Moldova. Since the beginning of the pandemic, UN Moldova offered immediate support to the country, providing assistance in three main areas: health system preparedness, technical support and capacity building, and information and communication on COVID-19.  WHO leads the support of the country’s preparedness to receive and administer vaccines. “Vaccines will be a critical new tool in the battle against COVID-19: It is encouraging to see so many vaccines in development. Working as quickly as they can, scientists from across the world are collaborating and innovating to bring us tests, treatments and vaccines that will collectively save lives and end this pandemic,” said Dr Igor Pokanevych, WHO Representative in the Republic of Moldova. ”However, vaccines alone will not end the pandemic. Ongoing public health measures to prevent transmission will still be needed alongside vaccination, including adhering to testing and quarantine measures, mask wearing, hand hygiene and physical distancing.” UNICEF is leveraging its experience as the largest single vaccine buyer in the world and working with manufacturers and partners on the procurement of anti-COVID-19 vaccine doses, as well as freight, logistics and storage. UNICEF already procures more than 2 billion doses of vaccines annually for routine immunization and outbreak response on behalf of nearly 100 countries.  “Vaccines are among the greatest advances of modern medicine. Sustainable supply of the vaccines is the only way out of this crisis, to ensure that vaccination is available for all,” said Maha Damaj, UNICEF Moldova Country Representative. “UNICEF looks forward to these vaccines being made available to the people most at risk, and to further ensuring that routine immunization services for other life-threatening infections are not disrupted.” Since the beginning of the pandemic, more than 180,000 Moldovans, including more than 10,000 children and more than 800 pregnant women, were infected with the virus and over 4,000 lives were lost because of Covid-19 infection.  The virus was confirmed to have reached the Republic of Moldova on 7 March 2020, when a Moldovan woman that returned from Italy was tested positive for the novel coronavirus.  Romania shipped the first donation of AstraZeneca’s COVID-19 vaccine to Moldova on 27 February, allowing Moldova to start vaccinating frontline medical workers on 2 March. Коробки с вакцинами UNICEF Moldova/ Vladimir Uvarov
Press release
16 Февраль 2021
Leading airlines commit to helping UNICEF in its historic mission of transporting COVID-19 vaccines around the world
https://www.unicef.org/eca/press-releases/leading-airlines-commit-helping-unicef-its-historic-mission-transporting-covid-19
COPENHAGEN, 16 February 2021 – UNICEF is today launching the Humanitarian Airfreight Initiative. Under this landmark initiative, over  10 leading airlines  are signing agreements with UNICEF to support the prioritization of delivery of COVID-19 vaccines, essential medicines, medical devices and other critical supplies to respond to the pandemic. The Initiative will also act as a global logistics preparedness mechanism for other humanitarian and health crises over the longer term.  “Delivery of these life-saving vaccines is a monumental and complex undertaking, considering the sheer volumes that need to be transported, the cold chain requirements, the number of expected deliveries and the diversity of routes” said Etleva Kadilli, Director of UNICEF Supply Division. “We are grateful to these airlines for joining forces with the UNICEF Humanitarian Airfreight Initiative to support the roll-out of COVID-19 vaccines.” The UNICEF Humanitarian Airfreight Initiative brings together the airlines covering routes to over 100 countries, in support of  the COVAX Facility  – the global effort aimed at equitable access to COVID-19 vaccines. Based on the COVAX Facility’s indicative distribution and first round allocation plan, 145 countries will receive doses to immunize around three per cent of their population, on average, starting in the first half of 2021, subject to all requirements being met and final allocation plans. In addition to prioritizing shipments of these life-saving supplies, the airlines will take measures such as temperature control and security, while also adding freight capacity to routes where needed. Their commitments are critical to the timely and secure delivery of vaccines and critical supplies.  Safe, timely and efficient transportation of life-saving supplies is critical to supporting access to essential services for children and families. COVAX deliveries and the subsequent vaccination of frontline workers will support health and social care systems to safely resume these critical services. Man next to a plane UNICEF/UNI319459/Rocio Ortega
Statement
14 Февраль 2018
Tackling sexual exploitation and abuse of children: Actions and commitments
https://www.unicef.org/eca/press-releases/tackling-sexual-exploitation-and-abuse-children-actions-and-commitments
STOCKHOLM, 14 February 2018 – “Sexual exploitation and abuse of children under any circumstances is reprehensible. No organization is immune from this scourge and we are continuously working to better address it. When it comes to the protection of children, we are determined to act. There is no room for complacency.  “As UNICEF’s Executive Director, I have put this issue at the top of our agenda and we are committed to strong action and transparency within UNICEF. “To make sure we are doing everything possible, we are commissioning an independent review of our procedures and I will make its recommendations public. “My team is also exploring ways to use technology to quickly assess the risks of sexual exploitation of abuse, and facilitate safe and confidential reporting by the victims.  “Starting in locations where the risk of sexual exploitation and abuse is higher, we are implementing more stringent vetting of all personnel and improving safety and protection around children in our operations. “These new measures add to the strong and determined actions we have taken over the years to prevent the abuse of children and respond to the needs of those affected, building on the lessons we have learned and a regular assessment of our approaches:  We have made the reporting of sexual exploitation and abuse mandatory, through a notification alert that reports information to me within 24 hours. We have scaled up our assistance to victims and are providing them with safe and confidential support; We are rolling-out community-based complaint mechanisms;  We have strengthened our investigations unit; and  We have made training on the prevention of sexual exploitation and abuse mandatory.  “We have zero tolerance for sexual exploitation and abuse, and we remain committed to continually learning and improving. We want justice for the child victims and are determined to work with all partners to achieve it.” Statement by UNICEF Executive Director Henrietta H. Fore.

Footer

Главная
  • Что мы делаем
  • Положение детей в регионе Европы и Центральной Азии
  • Где мы работаем
Исследования и отчеты
  • Публикации
  • Наши партнеры
  • Послы ЮНИСЕФ в Европе и Центральной Азии
Поддержать

Social - ru

Footer Secondary

  • Наши контакты
  • Условия пользования